InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by West Linda, Director. Officer active across 1 companies, notably Galera Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. Total volume traded: €531k. The latest transaction was disclosed on 17 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€48,35320,000 shares@ €2.417718.2% of flow
Common Stock
SEC:0000899243-21-049012·
Ideal exit: 13 Sept 2022 (T+270)
€48,35320,000 shares@ €2.41770.30% mcap9.1% of flow
Common Stock
SEC:0000899243-21-049012:0·
Ideal exit: 13 Sept 2022 (T+270)
€75,28610,000 shares@ €7.528628.4% of flow
Common Stock
SEC:0000899243-21-024505·
Ideal exit: 12 Mar 2022 (T+270)
€75,28610,000 shares@ €7.52860.47% mcap14.2% of flow
Common Stock
SEC:0000899243-21-024505:0·
Ideal exit: 12 Mar 2022 (T+270)
€70,85310,000 shares@ €7.085326.7% of flow
Common Stock
SEC:0000899243-21-022167·
Ideal exit: 27 Feb 2022 (T+270)
€70,85310,000 shares@ €7.08530.44% mcap13.4% of flow
Common Stock
SEC:0000899243-21-022167:0·
Ideal exit: 27 Feb 2022 (T+270)
€70,86710,000 shares@ €7.086726.7% of flow
Common Stock
SEC:0000899243-21-021576·
Ideal exit: 22 Feb 2022 (T+270)
€70,86710,000 shares@ €7.08670.44% mcap13.4% of flow
Common Stock
SEC:0000899243-21-021576:0·
Ideal exit: 22 Feb 2022 (T+270)
8 of 8 declarations
About West Linda
Linda West is a Director at Galera Therapeutics, Inc. In this role, she contributes to the governance of the company and strategic decision-making. Her experience in the biopharmaceutical sector allows her to make significant contributions to board discussions.
